Soupart A, de Saint-Georges A, Salhadin A, Sztern B, Wybran J, Lustman F
Arch Intern Med. 1984 Oct;144(10):2092-3. doi: 10.1001/archinte.144.10.2092.
We report a case of a double M component appearing in the course of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD). Lymphocyte function, especially the decrease in T-suppressor cells, could play an essential role in the mechanisms of the disease. In the presence of an M component, the prognosis for AILD seems to be more pessimistic. Arguments for considering AILD as a premalignant disease are reviewed.
我们报告了一例在血管免疫母细胞性淋巴结病伴蛋白异常血症(AILD)病程中出现双M成分的病例。淋巴细胞功能,尤其是T抑制细胞的减少,可能在该疾病的发病机制中起重要作用。在存在M成分的情况下,AILD的预后似乎更为悲观。本文回顾了将AILD视为癌前疾病的相关论据。